Epidemiology and clinical outcomes associated with extensively drug-resistant (XDR) Acinetobacter in US Veterans' Affairs (VA) medical centers.
Margaret A FitzpatrickKatie J SudaLinda PoggenseeAmanda VivoMarissa WirthGeneva WilsonMartin EvansCharlesnika T EvansPublished in: Infection control and hospital epidemiology (2020)
The proportion of Acinetobacter baumannii in the VA that was XDR was low, but treatment options are extremely limited and clinical outcomes were poor. Prevention of healthcare-associated XDRAB infection should remain a priority, and novel antibiotics for XDRAB treatment are urgently needed.